SMO and pancreatic neoplasm: Inhibition of SMO with GDC-0449 in HCC and colon cancer led to decreased tumorigenesis [134] and SMO knockdown in pancreatic cancer caused a decrease in CSC population as well as the expression of NANOG, a stem cell self-renewal protein [136].